TrialStem cell research & therapy2022

Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.

Najmeh Kaffash Farkhad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.